Zepbound 7.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F5X93
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,745
Award facts
- Contract value 100% obligated
- $22,744.98 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $22,744.98 to AmerisourceBergen Drug Corp for the supply of Zepbound (semaglutide) 7.5 mg/0.5 mL pen injections on January 14, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of January 15, 2026. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor that serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999.99 million through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. The Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems utilize this contract vehicle to obtain essential pharmaceutical products across multiple therapeutic domains. AmerisourceBergen's demonstrated capability to compete successfully for federal medical supply contracts reflects its significant role in supporting military treatment facilities and government healthcare operations.
Quick answers
Who was awarded contract SPE2DR26F5X93?
SPE2DR26F5X93 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DR26F5X93 worth?
The government has obligated $22,745 on SPE2DR26F5X93.
Is contract SPE2DR26F5X93 an order under another contract?
Yes. SPE2DR26F5X93 is a delivery order under SPE2DR25D3101, an indefinite delivery contract.
Was contract SPE2DR26F5X93 competed?
The extent of competition for SPE2DR26F5X93 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award